Stock screenerAll disclosures →
EDGAR →
NEO
Conviction 72HealthcareScan · Mon, Aug 10, 2026NEO$16.63+0.36%
ResistanceSupportVol 14Insider sellCongress buyCongress sellVol MA14 2.73M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price16.63
Change+0.36%
Gap-0.30%
Rel volume0.34×
Avg volume3.07M
Avg $ vol45.99M
SMA 2014.93
SMA 5013.41
SMA 20011.02
Price vs 50+23.97%
Price vs 200+50.91%
MA stackbullish
50/200 cross—
Supertrendup · 14.14
RSI (14)66
MACD hist0.10
MACD crossbull · 5d
Stoch %K / %D92 / 88
ADX (14)38
+DI / −DI34 / 11
RSI divergence—
MACD divergence—
ATR %+4.89%
ADR %5.02%
52w high16.63
52w low5.80
From 52w high+0.00%
Above 52w low+186.72%
New 52w highYes
SqueezeOff
Bollinger width26.71%
%B0.93
Donchian pos92.27%
Donchian high16.93
Donchian low13.05
AVWAP (52w high)16.63
vs AVWAP high-0.01%
AVWAP (52w low)10.53
vs AVWAP low+57.91%
OBV trendUp
Chaikin MF (20)-0.04
Today vs 20d0.34×
Avg vol (14d)2.73M
Avg vol (20d)3.07M
Avg $ vol (20d)45.99M
Market cap2.17B
RS 3m (vs SPY)+76.99%
RS 6m (vs SPY)+32.91%
RS line new highYes
Trend template6/8
Technical rank92.1
1 week+4.99%
1 month+17.86%
3 months+85.60%
6 months+45.62%
1 year+188.72%
YTD+41.41%
P/E-20.05
P/B2.61
P/S—
P/FCF-99.43
EPS-0.0400
Div yield—
ROE-13.03%
ROA-8.02%
Debt/Eq0.41
Current4.42
EV/EBITDA-26.24
Gross margin—
Net margin—
Rev growth—
EPS growth-37.22%
Price target17.80
Target upside7.04%
Analyst ratingBuy
Institutional117.46%
Ent. value2.36B
Revenue67.75M
Net income-17.11M
Gross profit80.86M
Free cash flow-21.78M
IndustrySERVICES-TESTING LABORATORIES
ExchangeNasdaq
Shares out130.21M
Employees2.5K
ListedThu, Jan 25, 1996
Free float127M
Float %97.8%
Short interest13.76M
Days to cover6.0d
Short volume82.5%
Squeeze score67 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.01 vs −$0.06
Last surprise+83.3% beat
Setup gradeB
Conviction72 / 100
Pattern quality—
Tech rank92.1 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance15.31
Support11.55
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in NEO · 1 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Gilbert Cisneros house · D · CA · traded 2025-05-07 | Buy | $1K–$15K | 2025-05-07 | 2025-06-06 |
Insider activity
SEC Form 4 transactions in NEO · 4 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Aunan Greg D Chief Accounting Officer · Common Stock · 2026-08-04 | Sell | 20K | $321K | 2026-08-04 | 2026-08-06 |
Starrett Carolyn S Director · Stock Option (Right to Buy) · 2026-06-23 | Grant | 9.78K | — | 2026-06-23 | 2026-06-25 |
Starrett Carolyn S Director · Restricted Stock Unit · 2026-06-23 | Grant | 14.13K | — | 2026-06-23 | 2026-06-25 |
TETRAULT LYNN A. Director · Stock Option (Right to Buy) · 2026-06-01 | Other | — | — | 2026-06-01 | 2026-06-03 |
Perez David Brian Director · Stock Option (Right to Buy) · 2026-06-01 | Other | — | — | 2026-06-01 | 2026-06-03 |
Kelly Michael Aaron Director · Stock Option (Right to Buy) · 2026-06-01 | Other | — | — | 2026-06-01 | 2026-06-03 |
Gunn Neil Director · Stock Option (Right to Buy) · 2026-06-01 | Other | — | — | 2026-06-01 | 2026-06-03 |
KANOVSKY STEPHEN M Director · Stock Option (Right to Buy) · 2026-06-01 | Other | — | — | 2026-06-01 | 2026-06-03 |
TETRAULT LYNN A. Director · Restricted Stock Unit · 2026-06-01 | Grant | 15.97K | $0 | 2026-06-01 | 2026-06-03 |
Perez David Brian Director · Stock Option (Right to Buy) · 2026-06-01 | Grant | 11.07K | $0 | 2026-06-01 | 2026-06-03 |
SEC filings
EDGAR filings in NEO · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.